Polaryx Therapeutics PLYX Cash Flow Statement (2025-2026)

NASDAQ PLYX
$2.14 -0.02 (-0.93%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter) -5.05M-1.96M-1.38M
Share-based Compensation (Quarter) 4.45M7.60M0.47M7.60M
Cash from Operations (Quarter) -0.71M-2.06M-1.33M
Change in Working Capital
Change in Account Payables (Quarter) -0.02M0.38M-0.17M
Change in Accured Expenses (Quarter) -0.09M0.01M
Other Working Capital Changes (Quarter) 0.00M0.40M-0.15M
Financing Activities
Cash from Financing Activities (Quarter) 0.25M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 0.25M
Additional items
Change in Cash (Quarter) -0.46M-2.06M8.46M
Free Cash Flow (Quarter) -0.71M-2.06M-1.33M
Net Cash Flow (Quarter) -0.46M-2.06M-1.33M